Latest AI News
Everbloom built an AI to turn chicken feathers into cashmere
Everbloom has also developed a chemical process to transform waste fibers and feathers into upcycled materials that resemble everything from polyester to cashmere.
JPMorgan Chase AI strategy: US$18B bet paying off
JPMorgan Chase’s AI strategy is delivering measurable returns – but at a human cost. The bank isn’t hiding the fact. With 200,000 employees now using its proprietary LLM Suite platform...
Evaluating AI’s ability to perform scientific research tasks
OpenAI introduces FrontierScience, a benchmark testing AI reasoning in physics, chemistry, and biology to measure progress toward real scientific research.
AI literacy and continuous education are cornerstones
Across the US, workers are experiencing a seismic shift in workplace operations as AI literacy becomes a core part of business strategies. This is redefining roles and expectations, while workloads...
Measuring AI’s capability to accelerate biological research
OpenAI introduces a real-world evaluation framework to measure how AI can accelerate biological research in the wet lab. Using GPT-5 to optimize a molecular cloning protocol, the work explores both...
Black box AI isn’t enough: Why enterprise consulting is moving to grounded models
Presented by SAPIn an era where anyone can spin up an LLM, the real differentiator isn’t the AI technology itself, but the institutional knowledge it’s grounded in. Internal and partner...
“Robot, make me a chair”
Computer-aided design (CAD) systems are tried-and-true tools used to design many of the physical objects we use each day. But CAD software requires extensive expertise to master, and many tools...
VCs discuss why most consumer AI startups still lack staying power
The next consumer tech revolution may require an introduction of a new personal device.
The new ChatGPT Images is here
The new ChatGPT Images is powered by our flagship image generation model, delivering more precise edits, consistent details, and image generation up to 4× faster. The upgraded model is rolling...
OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation
Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.